Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia

Annals of Neurology

Volumn 62, Issue 6, 2007, Pages 656-665

  Hehr, Ute ^a   Bauer, Peter ^b   Winner, Beate ^a   Schule, Rebecca ^c   Olmez, Akguen ^d   Koehler, Wolfgang ^e   Uyanik, Goekhan ^a   Engel, Anna ^b   Lenz, Daniela ^b   Seibel, Andrea ^c   Hehr, Andreas ^a   Ploetz, Sonja ^a   Gamez, Josep ^f   Rolfs, Arndt ^g   Weis, Joachim ^h   Ringer, Thomas M ⁱ   Bonin, Michael ^b   Schuierer, Gerhard ^j   Marienhagen, Joerg ^a   Bogdahn, Ulrich ^a   Weber, Bernhard H F ^a   Topaloglu, Haluk ^d   Schols, Ludger ^c   Riess, Olaf ^b   Winkler, Juergen ^a   more..

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d HACETTEPE UNIVERSITY   (Turkey)

^e Hospital General Vall d'Hebron ^*  (Germany)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITY OF ROSTOCK   (Germany)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^j UNIVERSITY HOSPITAL REGENSBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN ATROPHY; BRAIN METABOLISM; CHROMOSOME 15Q; CLINICAL ARTICLE; COGNITIVE DEFECT; CORPUS CALLOSUM; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRAMESHIFT MUTATION; FRONTAL CORTEX; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MOTOR DYSFUNCTION; NERVE BIOPSY; NERVE FIBER TRANSPORT; NERVE PROJECTION; NEUROLOGIC EXAMINATION; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SPASTIC PARAPLEGIA; SPASTIC PARAPLEGIA RATING SCALE; SPATACSIN GENE; SURAL NERVE; ULTRASTRUCTURE; WALKING DIFFICULTY; WHITE MATTER;

ADULT; BRAIN; CEREBRAL CORTEX; CODON, NONSENSE; COGNITION; CORPUS CALLOSUM; FEMALE; FRAMESHIFT MUTATION; GENES, RECESSIVE; HUMANS; LONGITUDINAL STUDIES; MUTATION; NERVE FIBERS, UNMYELINATED; PEDIGREE; POSITRON-EMISSION TOMOGRAPHY; PROTEINS; SEVERITY OF ILLNESS INDEX; SPASTIC PARAPLEGIA, HEREDITARY; SURAL NERVE; THALAMUS; WALKING;

EID: 37849037355     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21310     Document Type: Article

References (34)

1. Fink JK. Hereditary spastic paraplegia. In: Rimoin DL, Emery AEH, eds. Emery & Rimoin's Principles and Practice of Medical Genetics. 5th ed. Philadelphia: Churchill Livingstone Elsevier, 2007; 2771-2801.
2. Reid E. Science in motion: common molecular pathological themes emerge in rhe hereditary spastic paraplegias. J Med Genet 2003;40:81-86.
3. Behan WM, Maia M. Strümpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 1974;37:8-20.
4. Schule R, Holland-Letz T, Klimpe S et al. The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology 2006;67:430-434.
5. Harding AE. Classification of rhe hereditary ataxias and paraplegias. Lancet 1983;1:1151-1155.
6. Martinez Murillo F, Kobayashi H, Pegoraro E, et al. Genetic localization of a new locus for recessive familial spastic paraparesis ro 15q13-15. Neurology 1999;53:50-56.
7. Shibasaki Y, Tanaka H, Iwabuchi K, et al. Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15q13-15. Ann Neurol 2000;48:108-112.
8. Casali C, Valente EM, Bertini E, et al. Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology 2004;62:262-268.
9. Winner B, Uyanik G, Gross C, et al. Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol 2004; 61:117-121.
10. Winner B, Gross C, Uyanik G, et al. Thin corpus callosum and amyottophy in spastic paraplegia - case report and review of literature. Clin Neurol Neurosurg 2006;108:692-698.
11. Olmez A, Uyanik G, Ozgul RK, et al. Further clinical and genetic characterization of SPG11: hereditary spastic pataplegia with thin corpus callosum. Neuropediatrics 2006;37: 59-66.
12. Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 2007;39:366-372.
13. Chi CS, Mak SC, Schian WJ, Chen CH. Otal Glucose lactate stimulation test in mitochondrial disease. Pediatr Neurol 1992; 8:445-449.
14. Gempel K, Kiechl S, Hofmann S, et al. Screening for carnitine palmitoyltransferase deficiency by tandem mass spectrometry. J Inherit Metab Dis 2002;25:17-27.
15. Wain HM, Lush MJ, Ducluzeau F, et al. Genew: the Human Gene Nomenclature Database, 2004 updates. Nucleic Acids Res 2004;32:D255-D257.
16. Orlacchio A, Kawarai T, Totaro A, et al. Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol 2004;61:849-855.
17. Alber B, Pernauer M, Schwan A, et al. Spastin related hereditary spastic paraplegia with dysplastic corpus callosum. J Neurol Sci 2005;236:9-12.
18. Simpson MA, Cross H, Proukakis C, et al. Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 2003;73:1147-1156.
19. Al-Yahyaee S, Al-Gazali LI, De Jonghe P, et al. A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy. Neurology 2006;66:1230-1234.
20. França MC, D'Abreu A, Maurer-Morelli CV, et al. Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum. Mov Disord 2007;22:1556-1562.
21. Howard HC, Mount DB, Rochefort D, et al. The K-Cl co-transporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet 2002;32:384-392.
22. Uyanik G, Elcioglu N, Penzien J, et al. Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome. Neurology 2004;66:1044-1048.
23. Hentati A, Ouahchi K, Pericak-Vance MA, et al. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 1998;2:55-60.
24. Hubbard TJP, Aken BL, Beal K, et al. Ensembl 2007. Nucleic Acids Res 2007;35:D610-D617.
25. The Gene Ontology Consortium. Gene Ontology: tool for the unification of biology. Nat Genet 2000;25:25-29.
26. Letunic I, Copley RR, Pils B, et al. SMART 5: domains in the context of genomes and networks. Nucleic Acids Res 2006;34: D257-D260.
27. Mulder NJ, Apweiler R, Attwood TK, et al. New developments in the InterPro database. Nucleic Acids Res 2007;35:D224-D228.
28. Jmoudiak M, Futerman AH. Gaucher disease: pathological mechanisms and modern management. Br J Haemat 2005;129: 178-188.
29. Kleijer WJ, Hu P, Thoomes R, et al. Beta-mannosidase deficiency: heterogeneous manifestation in the first female patient and her brother. J Inherit Metab Dis 1990;13:867-872.
30. Keshavan M, Diwadkar VA, DeBellis M, et al. Development of the corpus callosum in childhood and adolescence and early adulthood. Life Sci 2002;70:1909-1992.
31. Pujol J, Vendrell P, Junque C, et al. When does the human brain development end? Evidence if the corpus callosum growth up to adulthood. Ann Neurol 1993;34:71-75.
32. von Richthofen S, Tabrizian S, Grabe HJ, Meyer B-U. Interhemispheric transfer and its implications for neurology and psychiatry. Fortschr Neurol Psychiat 2003;71:449-457.
33. Okubo S, Ueda M, Kamiya T, et al. Neurological and neuroradiological progression in hereditary spastic paraplegia with a thin corpus callosum. Acta Neurol Scand 2000;102:196-199.
34. Ohnishi J, Tomoda Y, Yokoyama K. Neuroradiological findings in hereditary spastic paraplegia with a thin corpus callosum. Acta Neurol Scand 2001;104:191-192.